Dean Remy Email & Phone Number

Boston, MA, US

San Francisco, US

Our Team is launching an AI-driven and IoT-enabled 3D/4D Virtualization Platform empowering Intelligent crisis and emergency response and global facility smart-management.

Co-launching a newco to develop both rapid POC and confirmatory tests for high-risk and ectopic pregnancies.

Responsibilities: Create commercial strategy around the co-development and technological partnerships, alliances, and KOL's; develop forecasts for the CRO business; build and manage the BD Team in the U.S & /EU; implement a CRM and necessary sales tools; build the initial C-Suite, Scientific and Investor Databases of @10K contacts; Lead Generation.

South San Francisco, CA, US

• Responsible for creating internal infrastructure and processes improvements to support the new North American BD efforts for the Marseille-site (formerly DBA Halio Dx). Identifying and securing contractual.
• Identify and develop cancer data development or out-licensing opportunities with pharma/biopharma key decision-makers
• Expand North American prospect list and details for MARCOM and BD outreach efforts
• Establish U.S. Pricing Sheet for Marseille-based Services and Tools
• Redesign of SFDC Implementation to ensure proper opportunity tracking and forecasting
• Deliver weekly reporting to Marseille Site Head Veracyte offers customized biomarker testing and analytical services to our biopharmaceutical partners, helping them advance their therapeutic discovery, development and.

Wilmington, Massachusetts, US

• Responsible for building and managing a small BD team and training & supporting the Discovery BD representatives and BD Management globally on large molecule opportunities. Identifying and securing contractual.
• Identify and develop out-licensing opportunities within vaccine, biopharmaceutical, CAR-T/NK/MAC and Cell & Gene Therapy companies of libraries & internal lead asset candidates.
• Ensure appropriate strategic solution is proposed to customer including customized Scopes of Work (SOW), pricing, service proposals and Master Service Agreements. Worked closely with our bioinformatic, structural.
• Introduced process reducing SOW turn-around from 4-5 weeks to 5-7 days and initiated program for secure, digital scope of work data capture and integration into SFDC to facilitate more complete automation of SOW.
• Create seamless cross-functional opportunities for the integration of the antibody discovery business unit into the larger organization
• Assure development of new messaging around “large molecule discovery” within presentations, web pages, social media content, slide decks and more.

Took leave to care for a family member nearly passing due to COVID-19

South San Francisco, California, US

• Responsible for identifying and securing contractual relationships and legal agreements with top global and well-funded pharmaceutical companies developing therapeutic antibodies, nanobodies (VHH’s) for the provision.
• Identify and develop COVID-19 therapeutic and diagnostic partners for licensing of the company’s internally developed antibodies and nanobodies.
• Ensure appropriate strategic solution is proposed to customer, monitoring actions and results against plans.
• Assure key risks and opportunities are identified, captured, and presented in an unbiased way to senior management for decision making.
• Drive contribution and consensus from colleagues for scientific, legal, logistics, finance, and commercial functions, leading term sheet and contract negotiations
• Expedite term sheets and master service agreements through the contract negotiation process for execution with velocity.

Hoddesdon, Herts, GB

• Responsible for strategic planning & partnerships securing new contractual relationships and legal agreements with most Top 20 global key pharma institutions, AgBio and Aquaculture organizations and Research Institutes.
• Drove above market growth rates for sciences manufacturing and services company whose genomic division provides ultra-high throughput (uHT) sample extraction and purification, qPCR instruments, tissue probes, research.
• Analyzed potential opportunities and develop sales plans for each target account.
• Adapted successful strategies and tactics to meet market demands and financial targets.

• Created and implemented the clinical trial validation and confirmatory protocols for all company 510k submittals involving NASA, Emory University, Sigma Aldrich, Becton Dickinson, and QUEST Diagnostics.
• Provided scientific direction and new market justification for the company product offering.
• Assisted with initial fundraising for $2M to enable pilot scale development and initial in-house testing, validation, and quality assurance (QA).
• Obtained FDA equivalent status for first product and initiated trials for 3 additional portfolio products.

• Created and implemented the clinical trail validation and confirmatory protocols for all company 510k submittals involving NASA, Emory University, Sigma Aldrich, Becton Dickinson, and QUEST Diagnostics.
• Provided scientific direction and new market justification for the company product offering.
• Assisted with initial fundraising for $2M to enable pilot scale development and initial in-house testing, validation, and quality assurance (QA).
• Obtained FDA equivalent status for first product and initiated trials for 3 additional portfolio products.

Boston, Massachusetts, US

• Built and executed a strategy for outreach and navigation of new large pharmaceutical accounts.
• Successfully communicated and positioned services to key stakeholders from current clients, to prospects, to board members, and investors.
• Develop strategic alliances and partnerships to bolster the company capabilities and offerings.
• Worked cross-functionally with product and operational leadership to ensure proper sales and product solution alignment.
• Implemented company-wide Customer Relationship Management (CRM) and Marketing program use and trainings.
• Developed the contract research organization (CRO) services contracts, pricing strategies, and created the value-prospectus.SmartLabs (formerly Mass Innovation Labs) now occupies 3 commercial properties around the life.

Fully oversaw biologic development site operations, management, sales and eventual restructuring for impending sale of entire entity to AbClonal. Six-month contract term.

Westborough, MA, US

• Responsible for sales performance; interpreted sales data analytics and market insights in order to translate into actionable strategies for the global sales team.
• Directed, inspired, coached, and motivated Regional Directors sales management and representatives to accomplish sales goals, managed large strategic contract negotiations.
• Provided data support for FDA, EU and assisted D-MAH with Japanese Medical Device submissions including STED for several pharmaceutical and medical device clients during their PMDA.
• Increased Life Science business by 203% in first 10 months and added 31 active referral accounts to company resources.
• 2011, 29% new client sales growth | 2012, 23% new client sales growth| 2013, 24% new client sales growth.

US

Most of the adaptations that could improve upon sales processes are counter to the infrastructure that most companies have implemented over the last 5-25 years. "The impediments to increasing sales in this new era are often institutionalized by the manufacturers themselves. Building a framework around a strategic and modular sales model, and offering it.

Basel, CH

Germany based amaxa manufactured a scientifically advanced system for the reproducible transfection system for work in primary mammalian and cell lines. Joined amaxa to build Industrial Sales Strategy with launch of new higher throughput technologies. Established tiered pricing programs for large Pharma customer base and generated and implemented.

Lincoln, NE, US

Managed the Sales & Business Development objectives for the Northeast U.S. and Eastern Canada for the LI-COR Bioscience' DNA Sequencing and Infrared Imaging systems including InVivo Imaging systems. Identified new application opportunities for IR and coordinated field evaluations.

Radnor, PA, US

Washington, DC, US

Performed laboratory testing supervision supporting all shifts. Performed sample collection (phlebotomy), processing and result confirmations. Performed all CLIA and CAP required Quality Control record-keeping and the necessary Clinical Laboratory Services including Chemistry, Special Chemistry, Immunology, Hematology, Coagulation, Urinalysis, Microscopy.

Managed Eastern U.S. Sales and client integration of an artificial intelligence-based automated Microscope & Software System (Micro21 HSA) at key targeted accounts. Additionally performed AI Software training on leukemic cell differentiation to enable systems to more efficiently identify the cellular variations optically resultant from variable staining.

Emeryville, California, US

Forchheim, DE

Brought on for launch of ACS:180 automated immunoassay platform providing in-house and field top-level support leading to development of System & Assay Troubleshooting programs including our proprietary A.I. Bright System. Was responsible for sales and technical support plus issue escalation and resolution for Key Accounts including Corning Clinical.

Boston, MA, US

Oversaw laboratory operations during night shifts. Performed required sample collection, processing and result confirmations. Performed all CLIA and CAP required Quality Control record-keeping and the Clinical Laboratory Services including Chemistry, Immunology, Hematology, Urinalysis and Microbiology. Performed also Electrocardiograms (ECG's) and, when.